SEARCH

SEARCH BY CITATION

References

  • Aakerlund L., Gether U., Fuhlendorff J., Schwartz T. W. and Thastrup O. (1990) Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase. FEBS Lett. 260, 7378.
  • Afework M., Tomlinson A. and Burnstock G. (1994) Distribution and colocalization of nitric oxide synthase and NADPH-diaphorase in adrenal gland of developing, adult and aging Sprague–Dawley rats. Cell Tissue Res. 276, 133141.
  • Bernet F., Dedieu J. F., Laborie C., Montel V. and Dupouy J. P. (1998) Circulating neuropeptide Y (NPY) and catecholamines in rat under resting and stress conditions. Arguments for extra-adrenal origin of NPY, adrenal and extra-adrenal sources of catecholamines. Neurosci. Lett. 250, 4548.
  • Van Biesen T., Luttrell L. M., Hawes B. E. and Lefkowitz R. J. (1996) Mitogenic signaling via G protein-coupled receptors. Endocr. Rev. 17, 698714.
  • Castagne V., Corder R., Gaillard R. and Mormede P. (1987) Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines. Regul. Pept. 19, 5563.
  • Cavadas C., Silva A. P., Mosimann F., Cotrim M. D., Ribeiro C. A., Brunner H. R. and Grouzmann E. (2001) NPY regulates catecholamine secretion from human adrenal chromaffin cells. J. Clin. Endocrinol. Metab. 86, 59565963.
  • Cavadas C., Grand D., Mosimann F., Cotrim M. D., Fontes Ribeiro C. A., Brunner H. R. and Grouzmann E. (2003) Angiotensin II mediates catecholamine and neuropeptide Y secretion in human adrenal chromaffin cells through the AT1 receptor. Regul. Pept. 111, 6165.
  • Cavadas C., Cefai D., Rosmaninho-Salgado J. et al. (2006) Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion. Proc. Natl Acad. Sci. USA 103, 1049710502.
  • Chan A. S., Yeung W. W. and Wong Y. H. (2005) Integration of G protein signals by extracellular signal-regulated protein kinases in SK-N-MC neuroepithelioma cells. J. Neurochem. 94, 14571470.
  • Chen S. H. and Cheung R. T. (2005) Neuropeptide Y and its receptor analogs differentially modulate the immunoreactivity for neuronal or endothelial nitric oxide synthase in the rat brain following focal ischemia with reperfusion. J. Biomed. Sci. 12, 267278.
  • Chen S. H., Fung P. C. and Cheung R. T. (2002) Neuropeptide Y-Y1 receptor modulates nitric oxide level during stroke in the rat. Free Radic. Biol. Med. 32, 776784.
  • Cox M. E. and Parsons S. J. (1997) Roles for protein kinase C and mitogen-activated protein kinase in nicotine-induced secretion from bovine adrenal chromaffin cells. J. Neurochem. 69, 11191130.
  • Cox M. E., Ely C. M., Catling A. D., Weber M. J. and Parsons S. J. (1996) Tyrosine kinases are required for catecholamine secretion and mitogen-activated protein kinase activation in bovine adrenal chromaffin cells. J. Neurochem. 66, 11031112.
  • Daniels A. J., Lazarowski E. R., Matthews J. E. and Lapetina E. G. (1989) Neuropeptide Y mobilizes intracellular Ca2+ and increases inositol phosphate production in human erythroleukemia cells. Biochem. Biophys. Res. Commun. 165, 11381144.
  • Daniels A. J., Matthews J. E., Humberto Viveros O. and Lazarowski E. R. (1992) Characterization of the neuropeptide Y-induced intracellular calcium release in human erythroleukemic cells. Mol. Pharmacol. 41, 767771.
  • De la Fuente M., Bernaez I., Del Rio M. and Hernanz A. (1993) Stimulation of murine peritoneal macrophage functions by neuropeptide Y and peptide YY. Involvement of protein kinase C. Immunology 80, 259265.
  • Dimitrijevic M., Stanojevic S., Micic S., Vujic V., Kovacevic-Jovanovic V., Mitic K., Von Horsten S. and Kosec D. (2006) Neuropeptide Y (NPY) modulates oxidative burst and nitric oxide production in carrageenan-elicited granulocytes from rat air pouch. Peptides 27, 32083215.
  • Douglas W. W. (1968) Stimulus-secretion coupling: the concept and clues from chromaffin and other cells. Br. J. Pharmacol. 34, 453474.
  • Edvinsson L., Ekman R. and Thulin T. (1991) Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man. Regul. Pept. 32, 279287.
  • Ely J. A., Hunyady L., Baukal A. J. and Catt K. J. (1990) Inositol 1,3,4,5-tetrakisphosphate stimulates calcium release from bovine adrenal microsomes by a mechanism independent of the inositol 1,4,5-trisphosphate receptor. Biochem. J. 268, 333338.
  • Garcia A. G., Garcia-De-Diego A. M., Gandia L., Borges R. and Garcia-Sancho J. (2006) Calcium signaling and exocytosis in adrenal chromaffin cells. Physiol. Rev. 86, 10931131.
  • Hansel D. E., Eipper B. A. and Ronnett G. V. (2001) Neuropeptide Y functions as a neuroproliferative factor. Nature 410, 940944.
  • Heredia Mdel P., Delgado C., Pereira L., Perrier R., Richard S., Vassort G., Benitah J. P. and Gomez A. M. (2005) Neuropeptide Y rapidly enhances [Ca2+]i transients and Ca2+ sparks in adult rat ventricular myocytes through Y1 receptor and PLC activation. J. Mol. Cell. Cardiol. 38, 205212.
  • Herzog H., Hort Y. J., Ball H. J., Hayes G., Shine J. and Selbie L. A. (1992) Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. Natl Acad. Sci. USA 89, 57945798.
  • Heym C., Colombo-Benckmann M. and Mayer B. (1994) Immunohistochemical demonstration of the synthesis enzyme for nitric oxide and of comediators in neurons and chromaffin cells of the human adrenal medulla. Ann. Anat. 176, 1116.
  • Keffel S., Schmidt M., Bischoff A. and Michel M. C. (1999) Neuropeptide-Y stimulation of extracellular signal-regulated kinases in human erythroleukemia cells. J. Pharmacol. Exp. Ther. 291, 11721178.
  • Krause J., Eva C., Seeburg P. H. and Sprengel R. (1992) Neuropeptide Y1 subtype pharmacology of a recombinantly expressed neuropeptide receptor. Mol. Pharmacol. 41, 817821.
  • Kumakura K., Sasakawa N., Murayama N. and Ohara-Imaizumi M. (2004) Spatio-temporal regulation of neurotransmitter release by PKC; studies in adrenal chromaffin cells. Crit. Rev. Neurobiol. 16, 173179.
  • Liu H., McPherson B. C., Zhu X., Da Costa M. L., Jeevanandam V. and Yao Z. (2001) Role of nitric oxide and protein kinase C in ACh-induced cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 281, H191H197.
  • Malhotra R. K., Wakade T. D. and Wakade A. R. (1989) Cross-communication between acetylcholine and VIP in controlling catecholamine secretion by affecting cAMP, inositol triphosphate, protein kinase C, and calcium in rat adrenal medulla. J. Neurosci. 9, 41504157.
  • Mannon P. J. and Mele J. M. (2000) Peptide YY Y1 receptor activates mitogen-activated protein kinase and proliferation in gut epithelial cells via the epidermal growth factor receptor. Biochem. J. 350(Pt. 3), 655661.
  • Mannon P. J. and Raymond J. R. (1998) The neuropeptide Y/peptide YY Y1 receptor is coupled to MAP kinase via PKC and Ras in CHO cells. Biochem. Biophys. Res. Commun. 246, 9194.
  • McCullough L. A. and Westfall T. C. (1996) Mechanism of catecholamine synthesis inhibition by neuropeptide Y: role of Ca2+ channels and protein kinases. J. Neurochem. 67, 10901099.
  • McNeill B. and Perry S. F. (2005) Nitric oxide and the control of catecholamine secretion in rainbow trout Oncorhynchus mykiss. J. Exp. Biol. 208, 24212431.
  • Michel M. C. (1991) Receptors for neuropeptide Y: multiple subtypes and multiple second messengers. Trends Pharmacol. Sci. 12, 389394.
  • Michel M. C., Feth F., Stieneker M. and Rascher W. (1992) NPY and carbachol raise Ca2+ in SK-N-MC cells by three different mechanisms. Evidence for inositol phosphate-independent Ca2+ mobilization by NPY. Naunyn Schmiedebergs Arch. Pharmacol. 345, 370374.
  • Mihara S., Shigeri Y. and Fujimoto M. (1989) Neuropeptide Y-induced intracellular Ca2+ increases in vascular smooth muscle cells. FEBS Lett. 259, 7982.
  • Misra S., Murthy K. S., Zhou H. and Grider J. R. (2004) Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways. J. Pharmacol. Exp. Ther. 311, 11541162.
  • Nakamura M., Sakanaka C., Aoki Y., Ogasawara H., Tsuji T., Kodama H., Matsumoto T., Shimizu T. and Noma M. (1995) Identification of two isoforms of mouse neuropeptide Y-Y1 receptor generated by alternative splicing. Isolation, genomic structure, and functional expression of the receptors. J. Biol. Chem. 270, 3010230110.
  • Nie M. and Selbie L. A. (1998) Neuropeptide Y Y1 and Y2 receptor-mediated stimulation of mitogen-activated protein kinase activity. Regul Pept. 75–76, 207213.
  • Nilsson T., Lind H., Brunkvall J. and Edvinsson L. (2000) Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent. Can. J. Physiol. Pharmacol. 78, 251255.
  • Nishizuka Y. (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258, 607614.
  • O’Farrell M. and Marley P. D. (1999) Different contributions of voltage-sensitive Ca2+ channels to histamine-induced catecholamine release and tyrosine hydroxylase activation in bovine adrenal chromaffin cells. Cell Calcium 25, 209217.
  • Oset-Gasque M. J., Parramon M., Hortelano S., Bosca L. and Gonzalez M. P. (1994) Nitric oxide implication in the control of neurosecretion by chromaffin cells. J. Neurochem. 63, 16931700.
  • Oset-Gasque M. J., Vicente S., Gonzalez M. P., Rosario L. M. and Castro E. (1998) Segregation of nitric oxide synthase expression and calcium response to nitric oxide in adrenergic and noradrenergic bovine chromaffin cells. Neuroscience 83, 271280.
  • Ping P., Takano H., Zhang J., Tang X. L., Qiu Y., Li R. C., Banerjee S., Dawn B., Balafonova Z. and Bolli R. (1999) Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ. Res. 84, 587604.
  • Prieto D., Buus C., Mulvany M. J. and Nilsson H. (1997) Interactions between neuropeptide Y and the adenylate cyclase pathway in rat mesenteric small arteries: role of membrane potential. J. Physiol. 502(Pt. 2), 281292.
  • Rosmaninho-Salgado J., Alvaro A. R., Grouzmann E., Duarte E. P. and Cavadas C. (2007) Neuropeptide Y regulates catecholamine release evoked by interleukin-1beta in mouse chromaffin cells. Peptides 28, 310314
  • Schwarz P. M.., Rodriguez-Pascual F., Koesling D., Torres M. and Forstermann U. (1998) Functional coupling of nitric oxide synthase and soluble guanylyl cyclase in controlling catecholamine secretion from bovine chromaffin cells. Neuroscience 82, 255265.
  • Selbie L. A., Darby K., Schmitz-Peiffer C., Browne C. L., Herzog H., Shine J. and Biden T. J. (1995) Synergistic interaction of Y1-neuropeptide Y and alpha 1b-adrenergic receptors in the regulation of phospholipase C, protein kinase C, and arachidonic acid production. J. Biol. Chem. 270, 1178911796.
  • Sena C. M., Tome A. R., Santos R. M. and Rosario L. M. (1995) Protein kinase C activator inhibits voltage-sensitive Ca2+ channels and catecholamine secretion in adrenal chromaffin cells. FEBS Lett. 359, 137141.
  • Shoji-Kasai Y., Itakura M., Kataoka M., Yamamori S. and Takahashi M. (2002) Protein kinase C-mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cells. Eur. J. Neurosci. 15, 13901394.
  • Silva A. P., Cavadas C. and Grouzmann E. (2002) Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin. Chim. Acta 326, 325.
  • Smith C., Moser T., Xu T. and Neher E. (1998) Cytosolic Ca2+ acts by two separate pathways to modulate the supply of release-competent vesicles in chromaffin cells. Neuron 20, 12431253.
  • Strosberg A. D. (1991) Structure/function relationship of proteins belonging to the family of receptors coupled to GTP-binding proteins. Eur. J. Biochem. 196, 110.
  • Takekoshi K., Ishii K., Kawakami Y., Isobe K., Nanmoku T. and Nakai T. (2001) Ca(2+) mobilization, tyrosine hydroxylase activity, and signaling mechanisms in cultured porcine adrenal medullary chromaffin cells: effects of leptin. Endocrinology 142, 290298.
  • Tanaka K., Shibuya I., Nagamoto T., Yamashita H. and Kanno T. (1996) Pituitary adenylate cyclase-activating polypeptide causes rapid Ca2+ release from intracellular stores and long lasting Ca2+ influx mediated by Na+ influx-dependent membrane depolarization in bovine adrenal chromaffin cells. Endocrinology 137, 956966.
  • Teschemacher A. G. and Seward E. P. (2000) Bidirectional modulation of exocytosis by angiotensin II involves multiple G-protein-regulated transduction pathways in chromaffin cells. J. Neurosci. 20, 47764785.
  • Torres M., Ceballos G. and Rubio R. (1994) Possible role of nitric oxide in catecholamine secretion by chromaffin cells in the presence and absence of cultured endothelial cells. J. Neurochem. 63, 988996.
  • Toska K., Kleppe R., Armstrong C. G., Morrice N. A., Cohen P. and Haavik J. (2002) Regulation of tyrosine hydroxylase by stress-activated protein kinases. J. Neurochem. 83, 775783.
  • Vanderheyden P. M., Van Liefde I., De Backer J. P. and Vauquelin G. (1998) [3H]-BIBP3226 and [3H]-NPY binding to intact SK-N-MC cells and CHO cells expressing the human Y1 receptor. J. Recept. Signal Transduct. Res. 18, 363385.
  • Vicente S., Gonzalez M. P. and Oset-Gasque M. J. (2002) Neuronal nitric oxide synthase modulates basal catecholamine secretion in bovine chromaffin cells. J. Neurosci. Res. 69, 327340.
  • Warashina A. (1997) Involvement of protein kinase C in homologous desensitization of histamine-evoked secretory responses in rat chromaffin cells. Brain Res. 762, 4046.
  • Wocial B., Ignatowska-Switalska H., Pruszczyk P., Jedrusik P., Januszewicz A., Lapinski M., Januszewicz W. and Zukowska-Grojec Z. (1995) Plasma neuropeptide Y and catecholamines in women and men with essential hypertension. Blood Press. 4, 143147.
  • Zheng J., Zhang P. and Hexum T. D. (1997) Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process. Mol. Pharmacol. 52, 10271033.
  • Zheng J., Zhou G. and Hexum T. D. (2000) Neuropeptide Y secretion from bovine chromaffin cells inhibits cyclic AMP accumulation. Life Sci. 67, 617625.
  • Zhu J., Li W., Toews M. L. and Hexum T. D. (1992) Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process. J. Pharmacol. Exp. Ther. 263, 14791486.